Depyrogenated Sterile Empty Vials Market Size Outlook and Demand Expansion Across 2026–2030

Global Depyrogenated Sterile Empty Vials Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Depyrogenated Sterile Empty Vials Market Expected To Change Between 2026 And 2030?

The depyrogenated sterile empty vials market size has experienced significant expansion in recent years. It is forecast to grow from $3.79 billion in 2025 to $4.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.9%. The market’s past growth can be ascribed to increasing production volumes of injectable drugs, the expansion of sterile pharmaceutical manufacturing, intensified regulatory scrutiny regarding injectable safety, the advancement of biologics and vaccines, and the adoption of borosilicate glass for packaging.

The depyrogenated sterile empty vials market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach a size of $5.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. Factors driving this growth during the forecast period include the increasing demand for biologics and biosimilars, greater investments in aseptic fill-finish facilities, the expansion of contract manufacturing services, an elevated focus on contamination control, and the growing adoption of pre-sterilized packaging. Key trends anticipated during this period encompass the increasing use of high-purity injectable packaging, a rising demand for ready-to-fill vials, an intensified focus on endotoxin-free packaging standards, the expansion of automated depyrogenation processes, and a strengthened emphasis on regulatory-compliant primary packaging.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8562&type=smp

Which Economic Or Industry Drivers Are Impacting The Depyrogenated Sterile Empty Vials Market?

The rising global incidence of infectious diseases is anticipated to boost the depyrogenated sterile empty vials market. Infectious diseases refer to health conditions resulting from harmful microorganisms such as bacteria, viruses, parasites, and fungi. Depyrogenated sterile vials are employed for the storage of injectable medication involved in the treatment of infectious diseases. Furthermore, depyrogenated sterile empty vials are also utilized for the collection of laboratory samples. For instance, in February 2024, according to the Health Security Agency, a UK-based government agency, cases of tuberculosis (TB) in England increased by 10.7% in 2023 compared to 2022, with the number of cases climbing from 4,380 in 2022 to 4,850 in 2023. Therefore, the increasing prevalence of infectious diseases across the globe will stimulate the growth of the depyrogenated sterile empty vials market.

How Is The Depyrogenated Sterile Empty Vials Market Structured Across Different Segments?

The depyrogenated sterile empty vials market covered in this report is segmented –

1) By Product: 2 ML, 5 ML, 10 ML, 20 ML, >20 ML

2) By Packaging: Glass, Plastic

3) By End User: Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors

Which Trends Are Shaping The Future Of The Depyrogenated Sterile Empty Vials Market?

Prominent companies within the depyrogenated sterile empty vials market are concentrating on creating inventive products, including deep-cold freeze vials, to satisfy the escalating requirement for more secure and dependable biopharmaceutical storage and transit. These specialized sterile containers are engineered for the safe preservation of biological substances at exceedingly low temperatures, specifically from –80°C to –150°C. They serve to safeguard sensitive drugs, vaccines, and samples against degradation, uphold sterility, and guarantee product stability throughout prolonged storage and transportation. For example, in January 2024, SCHOTT Pharma AG & Co. KGaA, a specialty glass manufacturing firm from Germany, introduced EVERIC freeze vials. This new family of vials is specifically designed for mRNA and gene-therapy products that necessitate deep-cold storage and robust container integrity. Constructed from Type I borosilicate glass, the EVERIC freeze vials are produced and validated for ultralow temperature applications. They incorporate reinforced glass geometry and precise process controls to minimize breakage during freeze-thaw cycles, are compatible with standard lyophilization and cryogenic logistics, provide controlled dimensional accuracy for automated filling and capping lines, and are engineered to mitigate delamination and particulate risks while enhancing drug stability compared to conventional vials, rendering them appropriate for vaccines, gene-therapy vectors, and other temperature-sensitive biologics.

Which Major Players Dominate The Depyrogenated Sterile Empty Vials Market?

Major companies operating in the depyrogenated sterile empty vials market are APG Pharma, Corning Inc., DWK Life Sciences, Nipro PharmaPackaging, Schott AG, Thermo Fisher Scientific, Gerresheimer AG, Stevanato Group, SGD Pharma, Merck KGaA, SiO2 Materials Science, Shandong Pharmaceutical Glass Co. Ltd., West Pharmaceutical Services Inc., Ompi Srl, Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging Limited, Acme Vial and Glass Company LLC, Amposan S.A., BMT Corporation, Cangzhou Four Stars Glass Co. Ltd., Zhejiang Pharmaceutical-Packaging Co. Ltd.

Read the full depyrogenated sterile empty vials market report here:

https://www.thebusinessresearchcompany.com/report/depyrogenated-sterile-empty-vials-global-market-report

What Are The Top-Performing Regions Within The Depyrogenated Sterile Empty Vials Market?

North America was the largest region in the depyrogenated sterile empty vials market in 2025. The regions covered in the depyrogenated sterile empty vials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Depyrogenated Sterile Empty Vials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8562&type=smp

Browse Through More Reports Similar to the Global Depyrogenated Sterile Empty Vials Market 2026, By The Business Research Company

Sterile Medical Packaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/sterile-medical-packaging-global-market-report

Sterile Compounding Pharmacies Market Report 2026

https://www.thebusinessresearchcompany.com/report/sterile-compounding-pharmacies-global-market-report

Generic Oncology Sterile Injectable Market Report 2026

https://www.thebusinessresearchcompany.com/report/generic-oncology-sterile-injectable-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model